ES2012510A6 - Procedimiento para la produccion de derivados de calcitonina - Google Patents

Procedimiento para la produccion de derivados de calcitonina

Info

Publication number
ES2012510A6
ES2012510A6 ES8603267A ES8603267A ES2012510A6 ES 2012510 A6 ES2012510 A6 ES 2012510A6 ES 8603267 A ES8603267 A ES 8603267A ES 8603267 A ES8603267 A ES 8603267A ES 2012510 A6 ES2012510 A6 ES 2012510A6
Authority
ES
Spain
Prior art keywords
radical
alpha
amino acid
aminoacyl
calcitonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8603267A
Other languages
English (en)
Spanish (es)
Inventor
Francois Cardinaux
Janos Pless
Robert Helmut Buck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2012510A6 publication Critical patent/ES2012510A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES8603267A 1985-12-04 1986-12-03 Procedimiento para la produccion de derivados de calcitonina Expired - Lifetime ES2012510A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3542859 1985-12-04
DE3614784 1986-05-02

Publications (1)

Publication Number Publication Date
ES2012510A6 true ES2012510A6 (es) 1990-04-01

Family

ID=25838500

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8603267A Expired - Lifetime ES2012510A6 (es) 1985-12-04 1986-12-03 Procedimiento para la produccion de derivados de calcitonina

Country Status (20)

Country Link
US (1) US4758550A (enExample)
JP (1) JPH085916B2 (enExample)
KR (1) KR880006263A (enExample)
AU (1) AU600242B2 (enExample)
BE (1) BE905849A (enExample)
CH (1) CH671229A5 (enExample)
DK (1) DK580186A (enExample)
ES (1) ES2012510A6 (enExample)
FI (1) FI864939A7 (enExample)
FR (1) FR2590902B1 (enExample)
GB (1) GB2184729B (enExample)
GR (1) GR862836B (enExample)
HU (1) HUT44794A (enExample)
IL (1) IL80846A0 (enExample)
IT (1) IT1214754B (enExample)
LU (1) LU86697A1 (enExample)
NL (1) NL8602950A (enExample)
NZ (1) NZ218473A (enExample)
PT (1) PT83835B (enExample)
SE (1) SE8605189L (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051647A1 (es) * 1992-12-10 1994-06-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298474B1 (en) * 1987-07-08 1992-11-19 Mitsubishi Petrochemical Co., Ltd. Novel calcitonin derivative and salt thereof
AU609911B2 (en) * 1987-12-16 1991-05-09 Rorer International (Overseas) Inc. 8-glycine,16-x, des-19-leucine-calcitonin
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
US5153308A (en) * 1988-06-16 1992-10-06 Teijin Limited S-sulfonated calcitonin derivatives
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
EP0370165B1 (en) * 1988-11-24 1994-01-05 Mitsubishi Petrochemical Co., Ltd. Novel calcitonin derivative and salt thereof
EP0460064A4 (en) * 1989-02-23 1992-04-01 Rorer International (Holdings) Inc. Therapeutic aerosol formulations
US5204326A (en) * 1989-03-16 1993-04-20 Otsuka Pharmaceutical Co., Ltd. Polypeptide derivatives and calcium metabolism improving agent
DK0423326T3 (da) * 1989-04-21 1999-05-25 Tsumura & Co Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
US5175146A (en) * 1989-12-05 1992-12-29 Vical, Inc. Synthetic calcitonin peptides
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
CS89491A3 (en) * 1990-04-09 1992-01-15 Chugai Pharmaceutical Co Ltd Hybrid calcitonin
JPH08505393A (ja) * 1992-12-31 1996-06-11 ザイモジェネティクス，インコーポレイティド 誘導体化カルシトニン
US5710244A (en) * 1992-12-31 1998-01-20 Labroo; Virender M. Derivatized calcitonins
AU1919595A (en) * 1994-02-09 1995-08-29 Brigham And Women's Hospital Gel-forming polypeptide derivatives
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
KR960031478A (ko) * 1995-02-14 1996-09-17 성재갑 유비퀴틴 융합 인간 칼시토닌의 정제방법
US6034064A (en) * 1995-04-07 2000-03-07 Hoechst Pharmaceuticals & Chemicals K.K. Peptides and therapeutic agent for autoimmune diseases containing the same
US5721207A (en) * 1995-04-18 1998-02-24 Innapharma, Inc. Method for treatment of pain
DE69943039D1 (de) 1998-02-13 2011-01-27 Amylin Pharmaceuticals Inc Neue verbindungen mit gemischter amylin aktivität
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
CA2643826A1 (en) * 2006-02-27 2008-06-12 Paul A. Wender Compositions and methods for transport of molecules with enhanced release properties across biological barriers
BR112014013697A2 (pt) * 2011-12-09 2020-11-03 The Regents Of The University Of California peptídeos mini-hepcidina modificados e métodos de uso dos mesmos
US9816066B2 (en) 2012-04-24 2017-11-14 The Regents Of The University Of California Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
GB1592969A (en) * 1976-09-13 1981-07-15 Armour Pharma Hentriacontapeptides and preparation thereof
WO1984003279A1 (en) * 1983-02-15 1984-08-30 Armour Pharma Des-asparagine-3 calcitonin
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
GB8327346D0 (en) * 1983-10-12 1983-11-16 Morris H R Peptide
US4497732A (en) 1983-10-21 1985-02-05 Armour Pharmaceutical Company 1A-Endo-glycine-calcitonin
US4537716A (en) 1983-12-05 1985-08-27 Armour Pharmaceutical Co. Des-serine2 or des-glycine2 -leucine22 calcitonin
US4622386A (en) * 1985-03-28 1986-11-11 Armour Pharmaceutical Company [1,7-di-alanine]calcitonin
US4658014A (en) * 1985-12-20 1987-04-14 Kempe Tomas G Synthetic peptides with calcitonin-like activity
AU7468687A (en) * 1987-06-23 1989-01-05 Armour Pharmaceutical Company (n-acyl, 1,7-di-alanine) calcitonin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051647A1 (es) * 1992-12-10 1994-06-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.

Also Published As

Publication number Publication date
AU6606186A (en) 1987-06-11
KR880006263A (ko) 1988-07-22
CH671229A5 (enExample) 1989-08-15
NZ218473A (en) 1990-03-27
IT1214754B (it) 1990-01-18
SE8605189D0 (sv) 1986-12-03
BE905849A (fr) 1987-06-03
PT83835A (en) 1986-12-01
JPH085916B2 (ja) 1996-01-24
IT8648701A0 (it) 1986-12-04
SE8605189L (sv) 1987-06-05
NL8602950A (nl) 1987-07-01
DK580186D0 (da) 1986-12-02
GB8628739D0 (en) 1987-01-07
GB2184729B (en) 1990-07-25
FI864939A0 (fi) 1986-12-03
LU86697A1 (fr) 1987-07-24
DK580186A (da) 1987-06-05
FR2590902B1 (fr) 1994-12-23
US4758550A (en) 1988-07-19
GB2184729A (en) 1987-07-01
FI864939A7 (fi) 1987-06-05
JPS62132898A (ja) 1987-06-16
GR862836B (en) 1987-04-02
FR2590902A1 (fr) 1987-06-05
PT83835B (pt) 1989-06-30
HUT44794A (en) 1988-04-28
AU600242B2 (en) 1990-08-09
IL80846A0 (en) 1987-03-31

Similar Documents

Publication Publication Date Title
SE8605189D0 (sv) New calcitonin derivaatives
ES2058347T3 (es) Nuevos acidos percarboxilicos imido-aromaticos.
ATE71947T1 (de) Tetrapyrrol-therapiemittel.
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
ES8505646A1 (es) Procedimiento para la preparacion de un derivado de insulina
ATE154641T1 (de) Neues physiologisch aktives schweinepeptid (cnp- 53)
EP0215410A3 (en) Retro-inverso hexapeptide neurotensin analogs, process for their preparation and pharmaceutical compositions containing them
SE9301911D0 (sv) New peptide derivatives
UA35592C2 (uk) Похідні оцтової кислоти
BG96978A (bg) Производни и аналози на 2-дезокси-2,3-дидехидро-n- ацетилнеураминовата киселина и използването им като противовирусни средства
ATE14439T1 (de) Veraenderte d-retro cyclische hexapeptide, analoge von somatostatin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69331721D1 (de) Neue carbamazepin hapten Analoge
IE781227L (en) New peptide derivatives.
ATE3283T1 (de) Somatostatin-analoge peptide, ihre herstellung und verwendung, sie enthaltende pharmazeutische praeparate und deren herstellung.
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
DE69029377D1 (de) Substituierungsanaloge von magaininpeptiden
GB1502573A (en) Somatostatin analogues
AU5901490A (en) Hemoregulatory peptides
ATE242202T1 (de) Peptide
ATE150028T1 (de) Neue ganglioside-derivaten
NO940006L (no) Aminosyrederivater
ES437586A1 (es) Procedimiento para la produccion de un peptido.
SE9000691D0 (sv) Vasoaktiva vasotocinderivat
KR840002346A (ko) 펩타이드의 제조방법
KR840006328A (ko) 펩티드의 제조방법